[Federal Register Volume 87, Number 130 (Friday, July 8, 2022)]
[Notices]
[Pages 40843-40844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-14590]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[Docket No. ATSDR-2022-0005]


Proposed Substances To Be Evaluated for Toxicological Profile 
Development

AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), 
Department of Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR) 
within the Department of Health and Human Services is initiating the 
development of another set of

[[Page 40844]]

Toxicological Profiles. This notice solicits public nominations of 
substances for ATSDR to evaluate for Toxicological Profile development.

DATES: All nominations, whether for substances on the Substance 
Priority List or for other substances, must be received by August 8, 
2022.

ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-
2022-0005, by either of the following methods:
     Federal eRulemaking portal at www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Office of Innovation and Analytics, Agency for Toxic 
Substances and Disease Registry, 4770 Buford Highway, Mail Stop S102-1, 
Atlanta, GA 30341-3717. Attn: Docket No. ATSDR-2022-0005.
    Instructions: All submissions must include the agency name and 
docket number for this notice. All relevant comments will be posted 
without change to http://www.regulations.gov, including any personal 
information provided. Do not submit comments by email. ATSDR does not 
accept comments by email. This means that no confidential business 
information or other confidential information should be submitted in 
response to this notice. Refer to the Submission of Nominations section 
(below) for the specific information required to be included in a 
nomination.

FOR FURTHER INFORMATION CONTACT: Kambria Haire, Office of Innovation 
and Analytics, Agency for Toxic Substances and Disease Registry, 1600 
Clifton Rd. NE, Mail Stop S102-1, Atlanta, GA 30329-4027; Email: 
[email protected]; Phone: 1-800-232-4636.

SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization 
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive 
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA 
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain 
requirements for ATSDR and the U.S. Environmental Protection Agency 
(EPA) concerning hazardous substances most commonly found at facilities 
on the CERCLA National Priorities List (NPL) (https://www.epa.gov/superfund/superfund-national-priorities-list-npl). Among these 
statutory requirements is a mandate for the Administrator of ATSDR to 
prepare Toxicological Profiles for each substance included on the 
Priority List of Hazardous Substances, also known as the Substance 
Priority list (SPL). This list identifies 275 hazardous substances 
found at NPL sites that ATSDR and EPA have determined currently pose 
the most significant potential threat to human health.

Substances To Be Evaluated for Toxicological Profile Development

    Each year, ATSDR develops a list of substances to be considered for 
Toxicological Profile development. The nomination process includes 
consideration of all substances on ATSDR's SPL, as well as other 
substances nominated by the public. For more information on ATSDR's 
SPL, visit https://www.atsdr.cdc.gov/SPL/.

Submission of Nominations for Toxicological Profile Development

    Today's notice invites voluntary public nominations of substances 
for toxicological profile development. If nominating a substance that 
is not on the SPL, please include the rationale for the nomination and 
any supporting data. ATSDR will evaluate data and information 
associated with nominated substances and will determine the final list 
of substances to be chosen for Toxicological Profile development. 
Substances will be chosen according to ATSDR's specific guidelines for 
selection. These guidelines can be found in the Selection Criteria, 
which may be accessed at https://www.atsdr.cdc.gov/toxprofiles/guidance/ATSDR_TP_Selection%20Criteria.pdf.

Pamela I. Protzel Berman,
Associate Director, Office of Policy, Planning and Partnerships, Agency 
for Toxic Substances and Disease Registry.
[FR Doc. 2022-14590 Filed 7-7-22; 8:45 am]
BILLING CODE 4163-70-P